证券之星消息,百洋医药(301015)04月07日在投资者关系平台上答复投资者关心的问题。投资者:请问,锝99mTc肼基烟酰胺聚乙二醇双环RGD肽注射液,稳定性实验数据补充完成了吗?是否已经重新提交审核?百洋医药董秘:投资者您好,锝99mTc肼基烟酰胺聚乙二醇双环RGD肽注射液目前正全力推进补充稳定性实验数据,待完成后重新提交,感谢您的关注与支持。投资者:“中方对原产于美国的所有进口商品加征34%...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.